Patent News

Oct. 16, 2017

Financial Times: Big Tech vs Big Pharma: the battle over US patent protection, by Rana Foroohar

This post originally appeared in the Financial Times and was re-posted on CNBC on October 16, 2017.

Sherry Knowles has a very personal interest in defending intellectual property — she believes it saved her life. Ms Knowles, herself a patent lawyer, fears that the treatment that helped her combat breast cancer, a medicine known as Adriamycin, would not have been produced if the tighter patent regulations introduced over the past decade had been in place when she fell ill.

As a former chief patent counsel at GlaxoSmithKline, Ms Knowles, who runs her own life sciences legal consulting firm, has a vested interest in defending IP laws. She knows that major pharmaceutical groups like GSK can only monetise new drugs based on their ability to patent innovations.